Skip to main content
Equibles
BBWI logo

BBWI · Bath & Body Works, Inc. · Metrics

Track BBWI — free

Use BBWI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BBWI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$20.55 +0.71 (+3.58%) At close · Oct 20
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$4.13B
Shares
201.65M
Volume · Oct 20 7.05M Avg daily vol (3M) 6.54M

BBWI metrics

110 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$20.55
Market cap
$4.13B

Price action

20 metrics
Price change (1W)
+14.0%
Price change (30D)
+17.3%
Price change (3M)
-3.3%
Price change (6M)
-5.1%
Price change (YTD)
-1.2%
Price change (1Y)
-25.1%
Trailing year
Price change (5Y)
-70.0%
52-week high
$27.05
52-week low
$14.85
Change from 52-week high
-26.7%
Change from 52-week low
+33.6%
Annualized volatility
60.5%
Annualized volatility (3M)
55.2%
Beta
1.4
RSI (14D)
63.4
Price vs SMA 50
+9.4%
Price vs SMA 200
+0.1%
Avg volume (3M)
6.51M
Relative volume
1.1
Average dollar volume
$120.51M

Company

3 metrics
Sector
Consumer Cyclical
Industry
Specialty Retail
Shares outstanding
201.65M

Valuation

12 metrics
P / E (TTM)
5.2
Trailing earnings · reciprocal yield 19.2%
PEG ratio
0.1
EV / revenue
1.0×
reciprocal yield 105.1%
EV / EBITDA
3.7×
reciprocal yield 27.1%
EV / EBIT
5.7×
reciprocal yield 17.6%
P / sales
0.6×
reciprocal yield 178.6%
P / book
—
FCF yield
25.5%
TTM · current market cap
Buyback yield
3.6%
P / FCF
3.9
reciprocal yield 25.5%
P / operating cash flow
3.2
reciprocal yield 31.5%
Earnings yield
19.3%

Historical valuation

8 metrics
P / E historical average (3Y)
8.4×
reciprocal yield 11.9%
P / E historical average (5Y)
9.0×
reciprocal yield 11.2%
EV / revenue historical average (3Y)
1.3×
reciprocal yield 74.6%
EV / revenue historical average (5Y)
1.4×
reciprocal yield 69.1%
EV / EBIT historical average (3Y)
7.9×
reciprocal yield 12.6%
EV / EBIT historical average (5Y)
7.8×
reciprocal yield 12.8%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
4.0%
Trailing 12 months
Payout ratio
20.7%
Shareholder yield
7.7%
Dividend / share (TTM)
$0.80
Dividend growth YoY
+0.0%
Dividend growth streak
0
Last ex-dividend
2026-08-21

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-26

Profitability

9 metrics
Gross margin
44.1%
Operating margin
16.7%
Trailing 12 months
Net margin
10.8%
Gross profit (TTM)
$3.18B
Operating profit (TTM)
$1.21B
Net income (TTM)
$781.00M
Trailing 12 months
Diluted EPS (TTM)
$3.80
FCF margin
14.3%
Effective tax rate
19.6%

Per share

11 metrics
Revenue per diluted share (TTM)
$35.41
Gross profit per diluted share (TTM)
$15.63
Operating profit per diluted share (TTM)
$5.93
EBITDA per diluted share (TTM)
$6.36
Net income per diluted share (TTM)
$3.84
Operating cash flow per diluted share (TTM)
$6.25
Free cash flow per diluted share (TTM)
$5.06
Capital expenditures per diluted share (TTM)
$1.19
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.11
Book value per share
$-6.37

Growth

11 metrics
Revenue growth YoY
-2.3%
Year over year
Net income growth YoY
+84.4%
Revenue (TTM)
$7.21B
Trailing 12 months
EPS growth YoY
+93.3%
Shares change YoY
-4.3%
Year over year · fewer shares
Revenue CAGR (3Y)
-1.2%
Revenue CAGR (5Y)
+2.5%
EPS CAGR (3Y)
-3.2%
EPS CAGR (5Y)
+0.7%
FCF CAGR (3Y)
+2.0%
FCF CAGR (5Y)
-13.7%

Quality

14 metrics
Return on equity
—
Return on assets
15.1%
Debt / equity
—
Current ratio
1.2
EBITDA (TTM)
$2.25B
Free cash flow (TTM)
$1.03B
Quick ratio
0.7
Interest coverage
4.5
Net debt / EBITDA
1.9
Return on invested capital
55.0%
Trailing 12 months
Net cash
−$2.82B
Latest balance sheet
Cash & equivalents
$794.00M
Total assets
$5.16B
Total debt
$3.61B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.27B
Capital expenditures (TTM)
$242.00M
R&D (TTM)
—
SG&A (TTM)
$1.98B
Stock compensation (TTM)
$23.00M
R&D / revenue
—
Stock compensation / revenue
0.3%

Ownership (13F)

9 metrics
13F filers
474
13F filer change QoQ
+1
Institutional ownership
105.1%
Conviction holders (share of 13F filers)
0.4%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-1.0%
Holder tenure
12.7
Price vs estimated holder cost
-8.0%

Ownership (registered funds)

1 metrics
Index-fund ownership
21.3%

Short interest

3 metrics
Short interest
10.2%
Latest settlement · 3.0 days to cover
Days to cover
3.0d
Short-squeeze score
65 / 100

Insider activity

2 metrics
Net insider buying (90D)
$0
Insider-sentiment score
61 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 701985 CUSIP 070830104 13F (30d) 54 filings 53 filers Visit website Investor relations